Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine
In non-human primates (NHPs) and humans, partial protection from HIV/SIV infection or suppression of replication is achievable by Env-binding antibodies and Gag-specific CD8+ T-cells targeting protective epitopes. Unfortunately, such T-cell responses are frequently dominated by responses to non-prot...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
24 May 2019
|
| In: |
Journal of translational medicine
Year: 2019, Volume: 17, Pages: 1-18 |
| ISSN: | 1479-5876 |
| DOI: | 10.1186/s12967-019-1924-1 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1186/s12967-019-1924-1
|
| Author Notes: | Melanie Schwerdtfeger, Anne-Marie Carola Andersson, Lasse Neukirch, Peter Johannes Holst |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1669553345 | ||
| 003 | DE-627 | ||
| 005 | 20240323101237.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190722s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12967-019-1924-1 |2 doi | |
| 035 | |a (DE-627)1669553345 | ||
| 035 | |a (DE-599)KXP1669553345 | ||
| 035 | |a (OCoLC)1341234170 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schwerdtfeger, Melanie |e VerfasserIn |0 (DE-588)1191119564 |0 (DE-627)1669551326 |4 aut | |
| 245 | 1 | 0 | |a Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine |c Melanie Schwerdtfeger, Anne-Marie Carola Andersson, Lasse Neukirch, Peter Johannes Holst |
| 264 | 1 | |c 24 May 2019 | |
| 300 | |a 18 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 22.07.2019 | ||
| 520 | |a In non-human primates (NHPs) and humans, partial protection from HIV/SIV infection or suppression of replication is achievable by Env-binding antibodies and Gag-specific CD8+ T-cells targeting protective epitopes. Unfortunately, such T-cell responses are frequently dominated by responses to non-protective, variable epitopes. In this study we attempt to combine three independent approaches, each developed to prevent immunodominance of non-protective epitopes. These approaches were (1) vaccines consisting exclusively of putatively protective p24 Gag highly conserved elements (CEs), (2) vaccines using solely subdominant antigens which were acutely protective in a recent NHP trial, and (3) virus-encoded virus-like particle vaccines (virus-like vaccines/VLVs) using heterologous Env and Gag sequences to enable selection of broadly cross-reactive responses and to avoid immunodominance of non-conserved sequences in prime-boost regimens as previously observed. | ||
| 700 | 1 | |a Andersson, Anne-Marie Carola |e VerfasserIn |0 (DE-588)1191119998 |0 (DE-627)166955242X |4 aut | |
| 700 | 1 | |a Neukirch, Lasse |d 1993- |e VerfasserIn |0 (DE-588)1191119319 |0 (DE-627)166955063X |4 aut | |
| 700 | 1 | |a Holst, Peter Johannes |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of translational medicine |d London : BioMed Central, 2003 |g 17(2019), Artikel-ID 175, Seite 1-18 |h Online-Ressource |w (DE-627)369084136 |w (DE-600)2118570-0 |w (DE-576)107015994 |x 1479-5876 |7 nnas |a Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine |
| 773 | 1 | 8 | |g volume:17 |g year:2019 |g elocationid:175 |g pages:1-18 |g extent:18 |a Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12967-019-1924-1 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190722 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 1191119319 |a Neukirch, Lasse |m 1191119319:Neukirch, Lasse |d 140000 |e 140000PN1191119319 |k 0/140000/ |p 3 | ||
| 999 | |a KXP-PPN1669553345 |e 3495500332 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title_sort":"Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine","title":"Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine"}],"person":[{"display":"Schwerdtfeger, Melanie","roleDisplay":"VerfasserIn","role":"aut","family":"Schwerdtfeger","given":"Melanie"},{"role":"aut","display":"Andersson, Anne-Marie Carola","roleDisplay":"VerfasserIn","given":"Anne-Marie Carola","family":"Andersson"},{"given":"Lasse","family":"Neukirch","role":"aut","roleDisplay":"VerfasserIn","display":"Neukirch, Lasse"},{"family":"Holst","given":"Peter Johannes","display":"Holst, Peter Johannes","roleDisplay":"VerfasserIn","role":"aut"}],"note":["Gesehen am 22.07.2019"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1669553345","origin":[{"dateIssuedDisp":"24 May 2019","dateIssuedKey":"2019"}],"id":{"eki":["1669553345"],"doi":["10.1186/s12967-019-1924-1"]},"name":{"displayForm":["Melanie Schwerdtfeger, Anne-Marie Carola Andersson, Lasse Neukirch, Peter Johannes Holst"]},"physDesc":[{"extent":"18 S."}],"relHost":[{"title":[{"title":"Journal of translational medicine","title_sort":"Journal of translational medicine"}],"part":{"pages":"1-18","year":"2019","extent":"18","volume":"17","text":"17(2019), Artikel-ID 175, Seite 1-18"},"pubHistory":["1.2003 -"],"language":["eng"],"recId":"369084136","type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccineJournal of translational medicine","note":["Gesehen am 22.06.20"],"id":{"issn":["1479-5876"],"eki":["369084136"],"zdb":["2118570-0"]},"origin":[{"publisherPlace":"London","dateIssuedDisp":"2003-","dateIssuedKey":"2003","publisher":"BioMed Central"}],"physDesc":[{"extent":"Online-Ressource"}]}]} | ||
| SRT | |a SCHWERDTFEVIRUSLIKEV2420 | ||